Related Experiment Video
Updated: Dec 16, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Saudi children with celiac disease: are they at risk of developing type-1 diabetes mellitus?
Omar I Saadah1, Ameera S ALsaiari2, Jamil A Al-Mughales3,4
1Pediatric Gastroenterology Unit, Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Insights
Saudi children with celiac disease (CeD) show a high prevalence of glutamic acid decarboxylase antibodies (GADA), a type of diabetes-associated autoantibody (DAA). Further research is needed before routine screening for DAA in CeD patients is recommended.
Area of Science:
- Endocrinology and Immunology
- Pediatric Gastroenterology
Background:
- Type-1 diabetes mellitus (T1DM) and celiac disease (CeD) share common genetic risk factors.
- Diabetes-associated autoantibodies (DAA) can be present in individuals with CeD.
- Understanding DAA prevalence in pediatric CeD is crucial for early detection and management.
Purpose of the Study:
- To determine the prevalence of DAA, specifically GADA and IA-2 antibodies, in children diagnosed with CeD.
- To compare DAA prevalence between children with isolated CeD and those with co-existing T1DM and CeD.
Main Methods:
- A cross-sectional study involving pediatric patients with CeD at King Abdulaziz University Hospital (2012-2014).
- Patients were categorized into two groups: isolated CeD (n=23) and combined CeD with T1DM (n=18).
- Enzyme-linked immunosorbent assay (ELISA) was used to measure GADA and IA-2 antibody levels.
Main Results:
- In the isolated CeD group, GADA prevalence was 69.6% and IA-2 was 4%.
- In the CeD with T1DM group, GADA prevalence was 66.7% and IA-2 was 22.2%.
- No statistically significant differences in GADA or IA-2 prevalence were observed between the two groups.
Conclusions:
- Saudi children with CeD exhibit a higher prevalence of GADA compared to findings in several Western studies.
- The study highlights a significant association between CeD and GADA in the pediatric population.
- Routine screening for DAA in children with CeD requires further investigation and long-term follow-up data.
Abstract:
Objectives Patients with type-1 diabetes mellitus (T1DM) and celiac disease (CeD) share the same genetic susceptibility alleles. The diabetes-associated autoantibodies (DAA) may be detected in CeD patients. The aim of this study is to describe the prevalence of DAA in children with CeD. Methods This is a cross-sectional study of children with CeD. The CeD patients were divided into two groups; group 1 (n=23) included patients with isolated CeD and group 2 included patients with combined T1DM and CeD. The study was conducted at King Abdulaziz University Hospital (KAUH) in 2012-2014. DAA, including glutamic acid decarboxylase antibodies (GADA) and protein tyrosine phosphatase-2 antibodies (IA-2), were measured by enzyme-linked immunosorbent assay (ELISA) in both groups. Clinical, demographic, and laboratory data were collected from the patients' medical charts. Results DAA were determined in 23 patients in group-1 and 18 patients in group-2. Group-1 comprised 43.5% males and 56.5% females; the mean age was 15 ± 3.7 years (with a range of 5-18 years). The prevalence of GADA and IA-2 was 69.6 and 4%, respectively. Group-2 comprised 55.6% males and 44.4% females; the mean age was 15.1 ± 2.8 years (with a range of 7-18 years). The prevalence of GADA and IA-2 was 66.7 and 22.2%, respectively. No significant differences were found between both groups in the prevalence of GADA (p=1.0) or IA-2 (p=0.15). Conclusions Saudi children with CeD have higher prevalence of GADA than reported in a number of other Western studies. Long-term follow-up data is required before recommending routine screening for DAA.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Psychoneuroimmunology: Diabetes and Cancer

